A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Why is this study being done?Cardiokidney Metabolic Syndrome or CKM is a new syndrome recognized by the American Heart Association and occurs when an individual has a combination of conditions which includes being overweight, in addition to having metabolic risk factors (hypertriglyceridemia [≥135 mg/dL], hypertension, metabolic syndrome, diabetes), or chronic …
Researchers at City of Hope (California), University of Alabama at Birmingham, and Indiana University are studying a medication called denosumab as a potential treatment for people with type 1 diabetes. Denosumab, also known as Prolia, is a drug that has been approved by the Food and Drug Administration for bone …
To confirm superiority of oral semaglutide at the maximum tolerated dose (3 mg, 7 mg or 14 mg)versus placebo on glycaemic control in children and adolescents (age 10 to less than 18 years) with type 2 diabetes on a background treatment of metformin or basal insulin or both.
RADIANT aims to discover and define rare and atypical forms of diabetes among individuals and families, by investigating and defining their molecular and metabolic bases, and developing processes as well as a database and biorepository to enhance further understanding of atypical diabetes by the broader research community. These refined diagnoses …
What is the purpose of this study?The purpose of this ancillary study to the iGDM randomized clinical trail is to determine whether CGM can reveal additional information about maternal glucose values above and beyond the information obtained from checking blood glucose values 4 times per day. THIS STUDY IS ENROLLING BY …
Researchers at Indiana University School of Medicine are conducting a study to find out how many people with acute pancreatitis develop diabetes. Diabetes is a known complication of acute pancreatitis. For some people, diabetes can last a few weeks after acute pancreatitis, but for others, it can appear a year or …
What is this study about?This study aims to understand how often patients develop diabetes mellitus after acute pancreatitis and understand its clinical characteristics. It also aims to identify risk factors that predict the development of diabetes mellitus.
What is the purpose of this study?This study is the long-term extension of the PRV-031-001 (PROTECT) study. PROTECT is a Phase 3, randomized, double-blind, placebo-controlled, multinational, multi-center study to evaluate the efficacy and safety of teplizumab, a humanized, anti-CD3 monoclonal antibody, in children and adolescents ages 8 through 17 recently …
We propose a study that incorporates mind-body skills with diabetes education specifically designed for adolescents with T1D. To our knowledge, this is the first of such a study in adolescents with T1D.
